CERTEST BIOTEC
Contact information
- Biomarkers
- In vitro diagnostics
- Drug delivery
- Drug development
- Drug discovery
- Gene Therapy
- Vaccines
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Infectious diseases
- Inflammatory diseases
- Immunology
- Oncology
- Digestive system and hepatology
- Respiratory and pulmonary system
- APIs and green chemistry
- Enzymes
- Manufacture of biotech equipment
- Microorganism
- Bioinformatics
Certest Biotec, S.L. is a company dedicated to healthcare biotechnology, focused on the development, manufacturing and commercialization of IVD and pharmaceutical products. It bases its growth on research and a highly qualified and customer service-oriented workforce. The company's purpose is to improve global health, giving an immediate response through our human potential.
In the pharmaceutical sector, Certest Pharma provides proprietary technology for the development of vaccines and therapies based on nucleic acids:
-
Delivery technologies: we are world leaders in novel ionizable lipids and design of thermostable formulations based on lipid nanoparticles (LNPs).
-
RNA technology: we offer proprietary UTRs, optimized sequences and synthesis services for mRNA, saRNA, circRNA and tRNA expression.
-
Oligonucleotides: design, development, scale-up and analysis of ASOs, PMOs& siRNA.
In the in vitro diagnostics sector, Certest develops and commercializes a wide range of solutions for immunodiagnostics and molecular diagnostics:
-
Raw materials: proteins, monoclonal antibodies, probes and primers.
-
Immunodiagnostics: rapid tests (lateral flow), turbidimetric tests and chemiluminescence kits and equipment.
-
Molecular diagnostics: a comprehensive solution for qPCR (including extraction, amplification, and equipment) and diagnostic kits for high-throughput sequencing by NGS, featuring a pipeline for data analysis and result interpretation.
- Diagnosis and treatment of infectious diseases
- Biomarkers
- Diagnosis and treatment of genetic diseases
- Oncology
- Nucleic acid-based therapies